Non–Clear Cell Renal Cancer: Features and Medical Management

Author： Heng Daniel Y. C.   Choueiri Toni K.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.7, Iss.6, 2009-06, pp. : 659-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy for Non-Clear Cell Histologies in Renal Cancer

By  

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

Non-aspirin NSAIDs increase risk of renal cell cancer

By  

Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Management of Metastatic Renal Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 1, 2005-01 ,pp. : 105-113

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 792-802

Bentham Science Publishers

Access to resources Recommend Favorite